{"schema_version":"secwatch.filing_event.v1","accession":"0001803737-24-000151","form_type":"8-K","ticker":"EHAB","cik":"0001803737","company_name":"Enhabit, Inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.576403+00:00","generated_at":"2026-05-31T12:27:55.654058+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enhabit Q2 net loss $0.2M; adj. EBITDA $25.2M; guides 2024 revenue $1.05-1.063B","bullets":["Net loss $0.2M (diluted EPS $0.00); adj. EPS $0.07; adj. EBITDA $25.2M, up 5.4% YoY.","Home health revenue $210.2M (-1.7%); total admissions +6.4% driven by non-Medicare +25.2%.","Hospice revenue $50.4M (+3.9%); average daily census +2.7% YoY, up sequentially each month since Jan.","2024 guidance: revenue $1.05-1.063B (vs prior $1.076-1.102B), adj. EBITDA $100-106M, adj. EPS $0.19-$0.37.","Reduced bank debt by $15M in quarter; opened one home health de novo in Florida."],"urls":{"canonical":"https://secwatch.observer/filing/0001803737-24-000151","json":"https://secwatch.observer/filing/0001803737-24-000151.json","markdown":"https://secwatch.observer/filing/0001803737-24-000151.md","text":"https://secwatch.observer/filing/0001803737-24-000151.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1803737/000180373724000151/0001803737-24-000151-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1803737/000180373724000151/ehab-20240806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:27:55.654058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}